Cytoplasmic Processing Is a Prerequisite for Presentation of an Endogenous Antigen by Major Histocompatibility Complex Class II Proteins

por Lich, John D., Elliott, John F., Blum, Janice S.
Publicado 2000

Characterization of NLRP12 during the Development of Allergic Airway Disease in Mice

por Allen, Irving C., Lich, John D., Arthur, Janelle C., Jania, Corey M., Roberts, Reid A., Callaway, Justin B., Tilley, Stephen L., Ting, Jenny P.-Y.
Publicado 2012

Characterization of NLRP12 during the In Vivo Host Immune Response to Klebsiella pneumoniae and Mycobacterium tuberculosis

por Allen, Irving C., McElvania-TeKippe, Erin, Wilson, Justin E., Lich, John D., Arthur, Janelle C., Sullivan, Jonathan T., Braunstein, Miriam, Ting, Jenny P. Y.
Publicado 2013

Correction: Characterization of NLRP12 during the In Vivo Host Immune Response to Klebsiella pneumoniae and Mycobacterium tuberculosis

por Allen, Irving C., McElvania-TeKippe, Erin, Wilson, Justin E., Lich, John D., Arthur, Janelle C., Sullivan, Jonathan T., Braunstein, Miriam, Ting, Jenny P. Y.
Publicado 2013

Criteria for effective design, construction, and gene knockdown by shRNA vectors

por Taxman, Debra J, Livingstone, Laura R, Zhang, Jinghua, Conti, Brian J, Iocca, Heather A, Williams, Kristi L, Lich, John D, Ting, Jenny P-Y, Reed, William
Publicado 2006

G-CSF drives autoinflammation in APLAID

por Mulazzani, Elisabeth, Kong, Klara, Aróstegui, Juan I., Ng, Ashley P., Ranathunga, Nishika, Abeysekera, Waruni, Garnham, Alexandra L., Ng, Sze-Ling, Baker, Paul J., Jackson, Jacob T., Lich, John D., Hibbs, Margaret L., Wicks, Ian P., Louis, Cynthia, Masters, Seth L.
Publicado 2023

Identification of an antibody‐based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissues

por Finger, Joshua N., Brusq, Jean‐Marie, Campobasso, Nino, Cook, Michael N., Deutsch, Jennifer, Haag, Heather, Harris, Philip A., Jenkins, Earl L., Joglekar, Devika, Lich, John D., Maguire, Sean, Nagilla, Rakesh, Rivera, Elizabeth J., Sun, Helen, Votta, Bartholomew J., Bertin, John, Gough, Peter J.
Publicado 2017

Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers

por Weisel, Kathleen, Scott, Nicola E., Tompson, Debra J., Votta, Bartholomew J., Madhavan, Sujith, Povey, Kat, Wolstenholme, Allen, Simeoni, Monica, Rudo, Todd, Richards‐Peterson, Lauren, Sahota, Tarjinder, Wang, J. Gene, Lich, John, Finger, Joshua, Verticelli, Adeline, Reilly, Michael, Gough, Peter J., Harris, Philip A., Bertin, John, Wang, Mei‐Lun
Publicado 2017

Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer

por Harris, Philip A., Marinis, Jill M., Lich, John D., Berger, Scott B., Chirala, Anirudh, Cox, Julie A., Eidam, Patrick M., Finger, Joshua N., Gough, Peter J., Jeong, Jae U., Kang, James, Kasparcova, Viera, Leister, Lara K., Mahajan, Mukesh K., Miller, George, Nagilla, Rakesh, Ouellette, Michael T., Reilly, Michael A., Rendina, Alan R., Rivera, Elizabeth J., Sun, Helen H., Thorpe, James H., Totoritis, Rachel D., Wang, Wei, Wu, Dongling, Zhang, Daohua, Bertin, John, Marquis, Robert W.
Publicado 2019